Validation of an electronic algorithm to identify appropriate antibiotic use for community-acquired pneumonia in
Kathleen Chiotos1,2,3,4, Lauren Dutcher5, Robert Grundmeier3,6
1Division of Critical Care Medicine, Department of Anesthesiology and Critical Care, https://ror.org/01z7r7q48Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Insights
Validated electronic algorithms can identify children with community-acquired pneumonia (CAP) and assess antibiotic use, aiding stewardship efforts. These tools show promise for improving antibiotic choice and duration monitoring in pediatric care.
Area of Science:
- Pediatric Infectious Diseases
- Health Informatics
- Antibiotic Stewardship
Background:
- Electronic health records (EHRs) offer potential for identifying pediatric community-acquired pneumonia (CAP) and evaluating antibiotic appropriateness.
- Validated measures for antibiotic choice and duration are currently lacking, hindering effective antibiotic stewardship.
Purpose of the Study:
- To develop and validate electronic algorithms for identifying children with CAP.
- To assess the appropriateness of antibiotic choice and duration in pediatric CAP cases using EHR data.
Main Methods:
- A cross-sectional study included hospitalized children (6 months–17 years) admitted between January 2019 and October 2022.
- Electronic CAP definition involved ICD-10 codes, imaging, and antibiotic initiation within 48 hours; exclusions applied for transfers, mortality, ICU stays, and concurrent infections.
- Manual chart review served as the reference standard to validate electronic measures of antibiotic choice and duration, calculating sensitivity, specificity, PPV, and NPV.
Main Results:
- The algorithm identified 1058 CAP encounters; 100 were randomly selected for validation.
- Manual review found inappropriate antibiotic choice in 1% and duration in 75% of cases.
- Electronic measures demonstrated high sensitivity and NPV for inappropriate choice (100%, 100%) and duration (97%, 92%), with good specificity (93% and 88%, respectively).
Conclusions:
- Electronic metrics for inappropriate antibiotic choice and duration exhibited acceptable performance.
- These validated algorithms can support syndrome-based antibiotic stewardship efforts in pediatric populations.
Background:
Algorithms using electronic health record data to identify children with community-acquired pneumonia (CAP) and to evaluate the appropriateness of antibiotic use may facilitate antibiotic stewardship efforts, but validated measures of antibiotic choice and duration are unavailable.
Methods:
We performed a cross-sectional study within a single hospital system, including hospitalized children ages 6 months to 17 years who were admitted between 1/1/2019 and 10/31/2022. CAP was defined electronically as an ICD-10 code for pneumonia, a chest x-ray or chest CT within 48 hours of admission, and at least two days of antibiotics starting within 48 hours of admission. Hospital transfers and those who died within 48 hours or had chronic conditions, intensive care unit stays ≥48 hours, or concurrent infections were excluded. We validated electronic measures of appropriate antibiotic choice and duration using a reference standard of manual chart review. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for each metric.
Results:
The electronic algorithm identified 1058 CAP encounters, and 100 were randomly selected for validation. Inappropriate antibiotic choice and duration occurred in one and 75 encounters of the 100 encounters, respectively, based on manual chart review. The electronic algorithm had a sensitivity of 100%, specificity of 93%, PPV of 14%, and NPV of 100% for inappropriate antibiotic choice and a sensitivity of 97%, specificity of 88%, PPV of 96%, and NPV of 92% for inappropriate antibiotic duration.
Conclusion:
Metrics of inappropriate antibiotic choice and duration had acceptable performance characteristics and may facilitate syndrome-based stewardship efforts.
More Related Videos
06:18Quantifying the Effects of Antimicrobials on In vitro Biofilm Architecture using COMSTAT Software
Published on: December 14, 2020
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Pyelonephritis II: Diagnostic Studies and Management
Antibiotic Selection
